OAR 333-505-0075: HIV Post-Exposure Prophylaxis

(1) Effective January 1, 2024, a hospital must adopt, maintain, and implement a policy for the dispensing of human immunodeficiency virus (HIV) post-exposure prophylaxis or therapies to a patient for occupational or nonoccupational exposure to HIV. (2) The policy must conform to the following guidelines except for as otherwise provided in section (3) of this rule: (a) Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Updated Guidelines for Antiretroviral Postexposure Prophylaxis after Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV, United States, 2016. (b) Centers for Disease Control and Prevention, Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis. (3) For any patient evaluated at the hospital within 72 hours of a possible occupational or nonoccupational exposure to HIV, a hospital shall ensure that: (a) Hospital personnel dispense to a patient at least a five-day supply of HIV post-exposure prophylactic medication or other therapies unless medically contraindicated; and (b) Information on the importance of starting and completing the medication regimen, as well as resources to ensure access to the full medication regimen, is provided to the patient at the time the first dose of the five-day supply is dispensed. (4) Hospital personnel must document in the patient’s medical record the date the post-exposure prophylaxis or therapies and information on starting and completing the medication regimen was distributed. NOTE: The guidelines cited in this rule are available from the agency.